Richmond Pharmacology Confirm event with the Department of International Trade
Posted:
8
August 2018
Richmond Pharmacology Confirm event with the Department of International Trade
Richmond Pharmacology is delighted to confirm an upcoming event alongside the Department of International Trade in the US.Early Phase Drug Development in the UK is to take place Friday 28th of September in Boston, MA.
The event which is to host speakers from both Richmond Pharmacology and UK regulators continues a long line of events staged between Richmond Pharmacology and the DIT around the world. Full details found below including how to express interest in attending the event.
Friday, 28 September 2018Time TBC
Café ArtScience650 East Kendall St,Cambridge, MA 02142
Richmond enrols first patients in Verve Therapeutic’s Heart-2 trial - pioneering a new approach to cardiovascular disease
June 27, 2024
Richmond enrols and doses the first patient in a clinical trial aimed at transforming the care of cardiovascular disease with single treatment gene-editing medicines.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
-min.jpg)
.jpg)
